Stefan Ciurea, MD, University of Texas MD Anderson Cancer Center, Houston, TX, talks on current stem cell sources in the haplo-SCT setting post-cyclophosphamide and evaluates whether bone marrow is the preferred stem cell source. This interview took place at the 5th International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) 2019, held in Berlin, Germany.
Speaker: Stefan Ciurea,Event: COSTEM 2019,Format: Interview,Field: Transplantation,Field: Treatment,Medicines: Cyclophosphamide,GVHD,complications,Bone marrow,CRS,
Stefan Ciurea, MD, University of Texas MD Anderson Cancer Center, Houston, TX, talks on current stem cell sources in the haplo-SCT setting post-cyclophosphamide and evaluates whether bone marrow is the preferred stem cell source. This interview took place at the 5th International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) 2019, held in Berlin, Germany.
0 Comments